Fig. 1From: CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancerThe DEGs which had differential expression between normal LNCaP cells and EnzR LNCaP cells from GSE44905, GSE78201 and GSE150807 datasets. A The upregulated DEGs between normal LNCaP cells and EnzR LNCaP cells from GSE44905, GSE78201 and GSE150807. B The downregulated DEGs between normal LNCaP cells and EnzR LNCaP cells from GSE44905, GSE78201 and GSE150807Back to article page